Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E-TWIST: Eptifibatide Following IVT in Acute Ischemic Stroke
NCT07347626Phase 3Not yet recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Mar 2026
- Primary completion
- Sep 2029
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eptifibatide in ischemic stroke, sponsored by Xinqiao Hospital. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
eptifibatide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07347626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07347626.